Arezu Z. Zuckermann-Aliabadi

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: December 13, 2023

Seeing is not knowing: risk, regulation, and the modern donor heart.

Seeing is not knowing: risk, regulation, and the modern donor heart.

Plasma Volume Score for Early Risk Stratification Following Heart Transplantation: An Exploratory Observational Study.

Plasma Volume Score for Early Risk Stratification Following Heart Transplantation: An Exploratory Observational Study.

Ascending aorta and aortic valve replacement in circulatory arrest via upper hemisternotomy: a step-by-step video.

Ascending aorta and aortic valve replacement in circulatory arrest via upper hemisternotomy: a step-by-step video.

Ferroptosis Blockade During Machine Perfusion: A New Lever for Donation After Circulatory Death Heart Transplantation?

Ferroptosis Blockade During Machine Perfusion: A New Lever for Donation After Circulatory Death Heart Transplantation?

The future of heart replacement therapy: four frontiers of transformation.

The future of heart replacement therapy: four frontiers of transformation.

Hypothermic oxygenated perfusion versus standard treatment of donor hearts in heart transplantation: extended follow-up of the NIHP2019 trial.

Hypothermic oxygenated perfusion versus standard treatment of donor hearts in heart transplantation: extended follow-up of the NIHP2019 trial.

"No Hearts Left Behind": A global proposal to rescue discarded donor hearts.

"No Hearts Left Behind": A global proposal to rescue discarded donor hearts.

Unlocking the black box of heart preservation.

Unlocking the black box of heart preservation.

Custodiol-N versus Custodiol: Results from a prospective noninferiority randomized single blind, multicenter phase 3 trial in patients undergoing heart transplantation.

Custodiol-N versus Custodiol: Results from a prospective noninferiority randomized single blind, multicenter phase 3 trial in patients undergoing heart transplantation.

Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival.

Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival.

Molecular states associated with dysfunction and graft loss in heart transplants.

Molecular states associated with dysfunction and graft loss in heart transplants.

Absolute Lymphocyte Count as a Marker for Cytomegalovirus Infection After Heart Transplantation.

Absolute Lymphocyte Count as a Marker for Cytomegalovirus Infection After Heart Transplantation.